Resultados de la búsqueda 231-240 of 12274 for Relaxin-2

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

  2. Transplant Center de Mayo Clinic - Ensayos clínicos

    Ir a página 22 · Ir a página 33 · SiguientePróxima página. A continuación se enumeran ensayos clínicos actuales. 22 estudios en Transplant Center (Centro de ...

  3. Neurología - Ensayos clínicos - Mayo Clinic

    ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The first part of the study includes the first two phases of therapy: Induction and Consolidation. This part will collect information on the leukemia, as well ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated ... (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype ...

  6. Neurología - Ensayos clínicos - Mayo Clinic

    ... 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated ... (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype ...

  7. Neurología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the efficacy and acceptability of point of care EEG collected via the Muse 2 device for delirium detection in ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

  9. Neurología - Ensayos clínicos - Mayo Clinic

    ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme ...

  10. Neurología - Ensayos clínicos - Mayo Clinic

    ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme ...